


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
DNTH
Dianthus Therapeutics
$88.72

Login to see Dianthus Therapeutics (DNTH) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Upgraded on attractively valued

Outperform the market
DNTH Price Performance
$87.39 (+1.52%)
$51.87 (+71.04%)
$41.83 (+112.10%)
$18.57 (+377.76%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
DNTH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DNTH Street Sentiment is unimpressive and have negative views on the near-term outlook
DNTH has Fair risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Dec 23, 2025
Reiterate
Outperform
Wedbush
Mar 10, 2026
Reiterate
Buy
Guggenheim
What is DNTH current stock price?
What is DNTH current Stock IQ?
What is DNTH RSI signal right now?
What is DNTH analyst price target and upside potential?
What do analysts say about DNTH stock?
What is DNTH momentum trend right now?
What are DNTH stock strengths?
What is DNTH Risk Level?
Should I buy DNTH stock right now?
Is DNTH a Strong Buy right now?
What is DNTH market cap and volume?
What factors influence DNTH's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
DNTH
Dianthus Therapeutics
Current Price
$88.72

DNTH Price Performance
$87.39 (+1.52%)
$51.87 (+71.04%)
$41.83 (+112.10%)
$18.57 (+377.76%)
DNTH Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
DNTH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DNTH Street Sentiment is unimpressive and have negative views on the near-term outlook
DNTH has Fair risk level

Overall Wall Street Rating
DNTH Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market
DNTH Trading Signals
DNTH is showing high volatility with an intraday swing of 9.47% (High: $87.93, Low: $80.32). This signals potential opportunities.
DNTH reported significant insider buying. Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems ish....
DNTH RSI crossed above 50, breaking into bullish territory (RSI: 50.2 vs previous 45.1)
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
DNTH Stock trends
DNTH Stock performance
DNTH Stock analysis
DNTH investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.